Press release
Microchips Accelerating the Evolution of Drug Device Sophistication
(Amherst, NH) - As therapeutic drug markets continue to evolve, advancements in drugs and devices are producing several positive improvements. New formulations are extending drug release profiles, leading to less frequent dosing. Enhancements in syringe and injector usability are increasing the number and types of therapeutics that can be self-administered.These advances have revealed a new set of concerns. Weekly, bi-weekly and monthly dosing deprives the patient of the repetitive reinforcement that is a key tenet of self-injection safety at a time when the dangers associated with powerful drug side effects are placing a priority on the need for accurate dosing and delivery. In response, device suppliers have been developing syringes and injectors with new technology, adding capabilities that address self-administration safety concerns. Using innovative technical solutions, these device features decrease patient reliance on recall, guiding them through the medication process and reducing the risk of drug dosing errors.
Capabilities enabled by microchips numerous and diversified, limited only by the goals of the designer, the level of device complexity that can be tolerated and the total device cost that the market application can support. Existing microprocessor controlled injectors include a wide range of features including patient authentication, injection customization, device power management which is important for higher end processors, data capture and transfer, and patient EMR integration.
To fully take advantage of the capabilities that microchips can support, designers incorporate additional components into the device design. These elements can include sensors, data displays and device-to-patient communication.
Microchip-enabled injection devices are being supplied across several device categories. Examples include single and multi-use autoinjectors, needle-free injectors, pen injectors and wearable SC injectors. As drug developers continue to formulate injectable drugs for sustained release to support less-frequent dosing, the perceived value of microchip-enabled devices that can effectively interact with patients, guiding them through the injection event and providing assurance that the dose was properly delivered will increase.
The evolving drug delivery device sector and the devices that are being designed to deliver them are detailed in a new and comprehensive report researched and written by Greystone Research Associates. Microchip Controlled Subcutaneous Drug Delivery Devices analyzes the technology, applications and therapeutic markets for injection devices that incorporate microprocessors to enable advanced patient features. The report also analyzes demand drivers, development factors, market considerations, and strategic and economic factors, and provides profiles of market sector participants.
More information is available at http://www.greystoneassociates.org
About Greystone
Greystone Research Associates is a medical technology consulting firm focused on the areas of medical market strategy, product commercialization, venture development, and market research. We assist medical and healthcare market participants in achieving their business objectives through the creation of detailed development strategies, product commercialization programs, and comprehensive market and technology research and analysis. Our market research publications are designed, researched and written to provide timely and insightful information and data on focused market segments, with the aim of providing market participants with the essential knowledge to refine and execute their marketing plans and financial targets.
Source: Greystone Research Associate
About Greystone
Greystone Research Associates is a medical technology consulting firm focused on the areas of medical market strategy, product commercialization, venture development, and market research. We assist medical and healthcare market participants in achieving their business objectives through the creation of detailed development strategies, product commercialization programs, and comprehensive market and technology research and analysis. Our market research publications are designed, researched and written to provide timely and insightful information and data on focused market segments, with the aim of providing market participants with the essential knowledge to refine and execute their marketing plans and financial targets.
Contact:
Mark Smith
Greystone Research Associates
98 Route 101A
Amherst, NH 03031 USA
Voice: 603-595-4340
Fax: 603-218-7020
www.greystoneassociates.org
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Microchips Accelerating the Evolution of Drug Device Sophistication here
News-ID: 738574 • Views: …
More Releases from Greystone Research Associates
Seeking to Capitalize on New Device Technology Drug Companies are Reformulating …
(Amherst, NH) – As the pace of competition increases within the pharmaceutical and biotech industries, the concept of life cycle management is becoming a key component of drug product management. Much of the recent emphasis in this area has centered on efforts to extend patent rights protection. While reformulation has been and is an important approach, efforts to prolong IP benefits have only recently involved IV-to-SC drug re-engineering. This migration…
Antibacterial Treatments that don’t Rely on Antibiotics Winding their way thro …
(Amherst, NH) – As bacteria grow resistant to conventional antibiotics, alternatives are being investigated, including antibodies, probiotics, bacteriophages, and antimicrobial peptides. The quest to replace the current generation of antibiotics is complicated by the methods that bacteria have acquired to evade attempts to destroy them – methods often referred to a virulence factors.
A microorganism can possess a wide array of virulence factors. They may only express these virulence factors when…
3D Printing Positioned to Address Issues that have Prevented Wide Adoption of Mi …
(Amherst, NH) – The promise of commercial microneedle drug delivery has been on the horizon for more than a decade. Like other compelling medical device innovations such as noninvasive glucose monitoring, the potential of the technology has yet to be realized due to the inability to solve the issues of reliable product performance from unit to unit and across a wide user population.
To fully address the unmet need these technologies…
Analysis of the Oncology Drug Pipeline Reveals Evolving Therapy Correlations and …
(Amherst, NH) – The almost two thousand active oncology clinical trials paint a picture of an evolving therapeutic sector that has established players moving quickly to realize the expanded benefits of recent treatment protocols. A dozen targeted treatments, using novel pathways and signaling, have achieved results that represent a new era in oncology and antineoplastic therapeutics. There approaches have attracted a growing number of drug developers anxious to profit from…
More Releases for Associate
JJC Law Welcomes Associate Attorney Grant Wood
New Orleans, LA – Louisiana’s JJC Law is delighted to announce the addition of Grant Wood to its highly regarded legal team.
Wood will help maintain the boutique law firm’s commitment to excellence by representing its clients primarily in the areas of motor vehicle accidents, premises liability, maritime and general personal injury.
JJC Law specializes in handling personal injury claims, claims against insurance companies (such as property/hurricane claims), and…
Alliance India crosses 1000 associate mark
Hyderabad: Alliance Global Services, the fastest growing provider of software design, development, and quality management services, announced on Tuesday that it has crossed the 1000 associate mark at its offshore delivery facility in Hyderabad, India. This significant growth milestone comes on the heels of new client acquisitions and engagements in the first quarter of 2015.
“We were less than 300 associates in India when we launched Alliance Global Services…
Brady Associate Receives National Standards Certification
GREENSBORO N.C. (June 29, 2011) — Brady (bradyservices.com), a company that provides high-efficiency HVAC systems and comprehensive building solutions for commercial and industrial facilities across North Carolina, announces today that Brian Smith has received Level II Analyst Certification by the Vibration Institute (vibration.org). The certification program is accredited by the American National Standards Institute.
Vibration analysis is an important part of maintaining peak performance for equipment that includes rotating parts. It…
New Associate Joins Williams Venker & Sanders
ST. LOUIS, MO – April 7, 2009 – Williams Venker & Sanders LLC is pleased to announce the addition of its newest associate, Matthew E. Pelikan (mpelikan@wvslaw.com). Matthew brings with him a strong background in litigation, specifically in the areas of toxic torts, labor and employment, worker’s compensation, products and premises liability and general commercial issues. He has handled every aspect of case management from acknowledgement through resolution,…
Fish & Richardson Adds Patent Prosecution Associate
AUSTIN, Texas – The national law firm of Fish & Richardson, P.C., is announcing the addition of Josh Tucker as an associate in the firm’s patent prosecution group.
Mr. Tucker joins the Austin office after serving as an associate at Houston’s Fletcher Yoder for the past three years, where he helped draft and prosecute patent applications.
He graduated with honors from the University of Texas School of Law in 2004,…
Fish & Richardson P.C. Adds New Associate
AUSTIN, Texas – The national law firm of Fish & Richardson, P.C., is announcing the addition of Chris R. Johnson as an associate in the firm’s litigation group.
Before joining Fish & Richardson, Mr. Johnson worked as a law clerk to the Hon. Alvin A. Schall of the United States Court of Appeals for the Federal Circuit. Mr. Johnson earned his law degree from Duke University in 2006, graduating magna cum…
